Thesis
Treatment outcome of combination therapy of sofosbuvir and daclatasvir for 12 weeks versus combination of sofosbuvir and ribavirin for 24 weeks in HCV Genotype 3 chronic hepatitis patients
Course: MD, Guide: Prof. Salimur Rahman
No other version available